Pricing Log in Create free account
Monday 2 November 2026 Export BAK’s income statement to Excel — free account

Braskem S.A.

BAK Basic Materials Chemicals

Braskem S.A.’s revenue for fiscal 2025 (year ended December 2025) was $12.7 billion, down 11.8% from fiscal 2024.

Revenue
+36.5%
EPS
+1,278.6%
Free cash flow
+611.1%
Total debt
−99.9%

Quarter to June 2026, against a year earlier

1.17 0.01 +0.86%
Market cap
$200.1M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
0.28
Beneish M
−1.53
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 56.72%

Capital & Financial Ratios $m

Size
Market Cap 200.13
Revenue ttm 13,435.30
Net income ttm 279.33
Free cash flow ttm (615.55)
Net debt Q 11.49
Valuation
P/E 0.00
Forward P/E —
Price / sales 0.03
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.00
Financial health
Current ratio Q 0.77 (below 1: weak)
Debt / equity Q 0.00 (negative: negative equity)
Interest coverage Q 1.22
Growth
Revenue growth Q +36.50% (above 0%: growing)
Operating income growth Q +100.11% (above 0%: growing)
EPS, this year +122.22% (at or above 15%: strong)
EPS, next year A −207.83% (below 0%: weak)
Revenue, next year A —
EPS, past 5 yrs —
EPS, next 5 yrs A +53.23% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.0×, against a ten-year median of 0.8×; over the ten years it ranged from −42.1× in 2021 to 1.4× in 2018.
P/S against its own 10 years 0.15%
10-year low 10-year high
EV/Sales against its own 10 years 0.15%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—
Growth, 2016–22
−12.3%/yr
  1. 1.49 ’16
  2. 0.78 ’17 −48%
  3. 0.41 ’19 −48%
  4. 2.63 ’21 +550%
  5. 0.67 ’22 −74%
paid

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 3,862 3,123 2,185 1
Receivables 1,127 1,206 1,401 1
Inventory 2,510 2,538 1,866 3
Other — 146 — 1
7,499 6,867 5,453 6
2023 2024 2025 Q'26
Payables 2,648 3,130 2,360 2
ST’ Debt 554 581 3,720 4
Other 821 606 385 0
4,906 5,242 7,203 8

Compound Annual Growth %

10y 5y 3y
Sales (1.30%) 2.20% (12.17%)
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value 0.00% 0.00% 0.00%

Earnings Trends EPS, adjusted, against the consensus

Jun 2026 Estimate 1.68 Actual 1.65

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Jun 2025 −0.70 −0.14 Beat by 0.56
Sep 2025 −0.48 −0.02 Beat by 0.46
Dec 2025 −0.98 0.48 Beat by 1.46
Jun 2026 1.68 1.65 Miss by 0.03
Sep 2026 0.31 — Reports 10 November 2026

EPS $

Mar Jun Sep Dec Year
’26 0.69 1.65 — — —
’25 0.30 (0.14) (0.02) (4.75) (4.44)
’24 (0.68) (1.80) (0.27) (2.42) (5.27)
’23 0.09 (0.42) (1.24) (0.80) (2.30)
’22 1.87 (0.72) (0.26) (0.41) (0.16)
’21 1.15 3.52 1.70 0.24 6.51
’20 (2.07) (1.16) (0.66) 0.68 (3.26)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 2,941 4,302 — — —
’25 3,322 3,152 3,176 3,016 12,665
’24 3,618 3,655 3,834 3,245 14,352
’23 3,743 3,587 3,415 3,390 14,135
’22 5,116 5,164 4,710 3,590 18,696
’21 4,153 4,988 5,417 5,015 19,572
’20 2,852 2,087 2,976 3,443 11,357
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (807) 806 — — —
’25 (398) (64) (144) (146) (752)
’24 195 267 (170) 160 451
’23 (539) 373 (507) 218 (455)
’22 327 426 545 437 1,734
’21 422 488 1,111 720 2,740
’20 484 (207) 180 764 1,221
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (935) 930 — — —
’25 (510) (182) (386) (235) (1,313)
’24 19 91 (300) (45) (235)
’23 (763) 186 (763) (7) (1,348)
’22 194 192 545 437 795
’21 422 264 951 477 2,113
’20 280 (276) 96 592 692
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

3.3
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 13,665 15,428 15,869 13,259 11,357 19,572 18,696 14,135 14,352 12,665 13,435 (0.8%) — — — —
Gross margin, % 26.69 26.56 19.95 12.32 19.15 30.35 11.77 4.28 7.75 2.20 1.49 (24.5) pt
EBT (40) 1,649 986 (1,166) (1,879) 3,328 9 (1,240) (3,288) (510) (374) +32.6%
EBT margin, % (0.29) 10.69 6.22 (8.80) (16.54) 17.00 0.05 (8.77) (22.91) (4.02) (2.79) (3.7) pt
Net income (28) 1,649 986 (1,166) (1,879) 3,328 9 (1,240) (3,288) (510) 279 +37.8%
Per share, $
Per share, $ Revenue 34.36 38.76 39.87 33.31 28.54 49.16 46.95 35.47 36.01 31.77 0.00 (0.9%)
Earnings (0.30) 3.21 1.97 (1.71) (3.26) 6.51 (0.16) (2.30) (5.27) (4.44) (2.43) +35.1%
Cash flow 3.42 1.94 6.36 1.44 3.07 6.88 4.35 (1.14) 1.13 (1.89) 0.00 n/m
Capex (2.07) (1.76) (1.80) (1.70) (1.33) (1.57) (2.36) (2.24) (1.72) (1.41) 0.00 (4.2%)
Free cash flow 1.35 0.18 4.56 (0.26) 1.74 5.31 2.00 (3.38) (0.59) (3.29) 0.00 n/m
Book value 1.24 4.31 3.89 2.51 (1.88) 2.89 2.97 1.65 (1.99) (7.41) 0.00 n/m
Shares, m 398 398 398 398 398 398 398 398 399 399 399 0.0%
Valuation, ×
Valuation, × P/E 0.00 8.30 11.87 0.00 0.00 3.25 17.00 0.00 0.00 0.00 0.00 4.0
P/S 0.36 0.70 0.61 0.44 0.32 0.43 0.08 0.24 0.11 0.09 0.03 0.3
P/B 10.10 6.33 6.29 5.89 0.00 7.30 1.03 5.21 0.00 0.00 0.00 4.2
EV/Sales 0.72 1.29 1.13 1.08 0.99 0.80 0.47 0.76 0.79 0.87 0.04 0.9
EV/FCF 18.40 321.54 9.79 (162.69) 15.98 7.97 9.00 (8.08) (51.11) (8.50) (0.79) 15.2
Cash, $m
Cash, $m Operating cash flow 1,361 771 2,531 574 1,221 2,740 1,734 (455) 451 (752) (291) n/m
Capex (824) (700) (714) (677) (529) (626) (939) (893) (687) (561) (324) (4.2%)
Free cash flow 537 71 1,816 (103) 692 2,113 795 (1,348) (235) (1,313) (616) n/m
Balance, $m
Balance, $m Working capital (1,944) (359) (474) 1,818 1,126 2,613 1,990 2,593 1,625 (1,750) (2) (1.2%)
Net debt 4,888 9,096 8,194 8,406 7,707 7,198 6,715 7,350 9,747 9,844 11 +8.1%
Shareholders’ equity 493 1,714 1,547 1,000 (750) 1,150 1,183 657 (793) (2,956) (2,590) n/m
Returns, %
Returns, % ROA (0.71) 7.72 4.75 (3.86) (7.64) 15.31 (0.38) (5.18) (11.28) (10.57) (5.71) (9.9) pt
ROIC 19.81 16.67 14.54 0.26 (0.13) 36.13 6.55 (4.37) (1.40) (2.94) 0.00 (22.7) pt
ROE (26.17) 109.69 47.45 (50.57) (1,040.70) 1,297.44 (5.57) (99.70) 3,078.28 94.41 314.45 +120.6 pt
People
People Employees 7,657 7,713 8,008 7,940 7,993 8,312 8,668 366 8,382 8,233 — +0.8%
Revenue/emp, $m 1.78 2.00 1.98 1.67 1.42 2.35 2.16 38.62 1.71 1.54 — (1.6%)
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 26 Oct 2026

Braskem S.A. vs peers in Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
GPRE Green Plains, Inc. $988.3M 7.9× 6.6× −19.28% (below 0%: shrinking) n/m +57.21% (above 0%: growing) 25.33% 15.21% Compare
LXU Lsb Industries Inc. $829.5M 23.0× 16.9× +11.10% (above 0%: growing) −325.00% (below 0%: shrinking) +9,653.02% (above 0%: growing) 6.82% (1.63%) Compare
WLKP Westlake Chemical Partners LP $749.3M 13.0× 14.2× −0.01% (below 0%: shrinking) −2.44% (below 0%: shrinking) +866.65% (above 0%: growing) 31.91% 29.39% Compare
TROX Tronox Holdings PLC $574.9M — (loss-making) — (loss-making) +18.74% (above 0%: growing) n/m +241.51% (above 0%: growing) 6.34% (2.42%) Compare
RYAM Rayonier Advanced Materials Inc. $447.1M — (loss-making) — (loss-making) +10.61% (above 0%: growing) n/m +69.92% (above 0%: growing) 6.10% (1.69%) Compare
ASIX AdvanSix $414.7M — (loss-making) — (loss-making) +2.75% (above 0%: growing) −89.74% (below 0%: shrinking) −49.21% (below 0%: shrinking) 7.38% 2.15% Compare
VHI Valhi, Inc. $399.6M — (loss-making) 7.0× +16.14% (above 0%: growing) +2,500.00% (above 0%: growing) +435.16% (above 0%: growing) 22.56% 9.88% Compare
BAK Braskem S.A. $200.1M — (loss-making) — +36.50% (above 0%: growing) n/m +611.13% (above 0%: growing) 0.00% 0.00%
NPT Texxon Holding Limited $39.9M — — — — −188.72% (below 0%: shrinking) — — Compare
Median of peers $511.0M 13.0× 10.6× +10.61% −46.09% +155.72% 7.38% 2.15%

All 15 Chemicals stocks →

Braskem S.A. (BAK) Latest News

20 Oct

Impact 4 · · PR Newswire

28 Sep

Impact 3 · · Zacks

25 Sep

Impact 4 · · MT Newswires

24 Sep

Impact 4 ·

18 Aug

Impact 4 ·
Impact 3 ·

17 Aug

Impact 3 ·

14 Aug

Impact 3 · · MarketBeat transcript

28 Jul

Impact 3 ·

18 Jun

Impact 4 ·
Impact 3 ·
Impact 3 ·

4 Jun

Impact 4 · · Zacks

14 May

Impact 4 · · MarketBeat

30 Mar

Impact 4 · · GuruFocus.com

27 Mar

Impact 4 · · MarketBeat

9 Mar

Impact 5 · · offshore-technology.com

28 Feb

Impact 3 · · Insider Monkey

29 Dec

Impact 4 · · Zacks

22 Dec

Impact 4 · · ZacksMT NewswiresZacksZacksZacksZacksZacksZacks

20 Nov

Impact 4 · · Business Wire

17 Nov

Impact 4 · · ZacksMT NewswiresInsider MonkeyInsider MonkeySimply Wall St.ZacksSimply Wall St.Zacks

11 Nov

Impact 4 · · GuruFocus.comGuruFocus.comGuruFocus.comGuruFocus.comGuruFocus.comGuruFocus.comGuruFocus.comGuruFocus.com transcript
Impact 4 · · PR NewswireInsider MonkeySimply Wall St.Simply Wall St.ZacksZacksAssociated Press FinanceInsider Monkey

30 Oct

Impact 4 · · GlobeNewswire

27 Oct

Impact 4 · · Business Wire

9 Oct

Impact 4 · · Business Wire

8 Oct

Impact 4 · · Business Wire

7 Oct

Impact 4 · · Business Wire

6 Oct

Impact 4 ·
stockrow.com/BAK · Data as of Oct 26, 2026 · For information only; not investment advice. · © 2026 stockrow.com